GemPharmatech Co (SHSE:688046) COGS-to-Revenue : 0.34 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co COGS-to-Revenue?

GemPharmatech Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥53.4 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥157.1 Mil.

GemPharmatech Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.34.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. GemPharmatech Co's Gross Margin % for the three months ended in Mar. 2024 was 65.99%.

GemPharmatech Co COGS-to-Revenue Historical Data

The historical data trend for GemPharmatech Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co COGS-to-Revenue Chart

GemPharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.33

0.28

0.26

0.29

0.32

GemPharmatech Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial												0.31	0.32	0.30	0.37	0.34

GemPharmatech Co COGS-to-Revenue Calculation

GemPharmatech Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	201.519	/	622.187
	=	0.32

GemPharmatech Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	53.421	/	157.087
	=	0.34

GemPharmatech Co (SHSE:688046) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

GemPharmatech Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	53.421 / 157.087
	=	65.99 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

GemPharmatech Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

GemPharmatech Co (SHSE:688046) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032

Website

https://www.gempharmatech.us

GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co (SHSE:688046) Headlines

No Headlines